A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independent by approximately 10–13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback